Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Study of 68Ga-HX01 PET Imaging in Healthy Volunteers and Patients with Solid Tumors
NCT06416774Phase 1Completed
- Start
- Dec 2022
- Primary completion
- Jul 2023
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of 68Ga-HX01 in solid tumor. Primary endpoints: Temperature at Day 2, Respiration at Day 2 and 6 more. Started Dec 2022; status: completed.
02
Drugs
68Ga-HX01
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT06416774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06416774.